Six ingredients is not one mechanism
Supplement pages like to settle on a single story — blood flow, usually,
because it is easy to picture. This formula does not work that way. There are four
distinct routes in here, they run on four different clocks, and the slowest of them
takes longer than most people keep taking anything.
Knowing which is which is the difference between a fair trial and a disappointed
one at week two.
Route one — circulation, through the smallest vessels
The flavone glycosides and terpene lactones in ginkgo leaf have been examined for
how blood moves through the narrowest vessels. Kaschel's 2011 trial is the best-known
controlled result: 188 healthy adults in their mid-forties to mid-fifties, a
standardised 240 mg extract, six weeks, and better recall of appointments they
had committed to.
Read that carefully, because the same trial found no advantage on recognition
memory. One kind of recall improved. Another did not. And two much larger trials
— the GEM study published in JAMA in 2008, which followed more than three
thousand older adults for six years, and Snitz the year after — found ginkgo
did not reduce dementia rates or slow broad cognitive decline.
Clock: roughly six weeks.
Route two — oxidative load in tissue
Curcumin, EGCG and lutein all act on oxidative stress. It is among the
better-supported explanations for how nerve tissue wears, and it is also the part of
this formula you will never detect. Nothing about it registers as a feeling.
The trial worth naming is Small's, published in 2018. Forty adults aged 51 to 84
took an absorbable curcumin form for eighteen months and finished ahead of placebo
on memory and attention scores. Forty people makes that a pilot, not a verdict —
and eighteen months is a long time to wait to find out.
Clock: months to a year and a half.
Route three — pigments that build up
Lutein and zeaxanthin accumulate in the retina and in nerve tissue over months.
You cannot rush it; the tissue takes them up at its own pace. Hammond's 2017 trial
gave 12 mg a day to adults and found an attention benefit — after a full
twelve months, with 51 participants left to analyse at the end.
Clock: a year.
Route four — the one thing that works today
L-theanine, alongside the modest caffeine that comes with green tea, moved attention
scores inside two hours in Haskell's 2008 crossover study. Nothing else in the capsule
operates on that timescale, and nothing else does anything at all on day one.
Scale matters here. The caffeine is well below a cup of coffee, and the measured
change is in how costly ordinary concentration feels rather than in how awake you are.
Nobody has ever mistaken this for an energy drink.
Clock: hours.
And the two with no route at all
Bamboo silica and D-Glucosamine Sulfate have no cognitive research behind them.
Not weak research — none. Silica has a documented job in connective tissue;
Jugdaohsingh's 2007 work is about bone, not thinking. D-Glucosamine is familiar from
joint shelves, and the largest dataset attached to it (Ma, BMJ 2019) looked at
cardiovascular outcomes, not memory.
They are in the formula as a mineral and structural contribution. We would rather
write that down than invent a mechanism for them.
What none of this means. These are mechanisms described in
research papers, not promises about your week. The reported effects are modest,
they arrive over weeks and months, and they were absent for a meaningful share of
the people in every trial above. An average across a group is not a forecast for
one person.
